Specialty  	Specialty  	 NN	B-NP
pharmacies  	pharmacies  	 NNS	I-NP
and  	and  	 CC	O
other  	other  	 JJ	O
restricted  	restricted  	 JJ	O
drug  	drug  	 NN	B-NP
distribution  	distribution  	 NN	I-NP
systems 	systems 	 NNS	I-NP
:  	:  	 :	O
financial  	financial  	 JJ	O
and  	and  	 CC	O
safety  	safety  	 NN	O
considerations  	considerations  	 NNS	O
for  	for  	 IN	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
health-system  	health-system  	 JJ	B-NP
pharmacists  	pharmacists  	 NNS	I-NP
To  	To  	 TO	O
discuss  	discuss  	 VB	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
restricted  	restricted  	 JJ	O
drug  	drug  	 NN	B-NP
distribution  	distribution  	 NN	I-NP
systems  	systems  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
implementation  	implementation  	 NN	B-NP
of  	of  	 IN	I-NP
risk  	risk  	 NN	I-NP
evaluation  	evaluation  	 NN	I-NP
and  	and  	 CC	O
mitigation  	mitigation  	 JJ	B-NP
strategies  	strategies  	 NNS	I-NP
( 	( 	 -LRB-	O
REMS 	REMS 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
health-system  	health-system  	 JJ	B-NP
pharmacists 	pharmacists 	 NN	I-NP
'  	'  	 POS	O
concerns  	concerns  	 NNS	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
specialty  	specialty  	 NN	B-NP
pharmacies  	pharmacies  	 NNS	I-NP
and  	and  	 CC	O
other  	other  	 JJ	O
restricted  	restricted  	 JJ	O
drug  	drug  	 NN	B-NP
distribution  	distribution  	 NN	I-NP
systems 	systems 	 NNS	I-NP
,  	,  	 ,	O
reimbursement  	reimbursement  	 JJ	B-NP
policies  	policies  	 NNS	I-NP
for  	for  	 IN	I-NP
high-cost  	high-cost  	 JJ	I-NP
specialty  	specialty  	 NN	I-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
supply  	supply  	 NN	B-NP
chain  	chain  	 NN	I-NP
models  	models  	 NNS	I-NP
for  	for  	 IN	O
traditional  	traditional  	 JJ	O
and  	and  	 CC	O
specialty  	specialty  	 NN	B-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
emerging  	emerging  	 VBG	B-NP
trends  	trends  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
management  	management  	 NN	O
of  	of  	 IN	O
and  	and  	 CC	O
reimbursement  	reimbursement  	 NN	B-NP
for  	for  	 IN	I-NP
specialty  	specialty  	 NN	I-NP
pharmaceuticals 	pharmaceuticals 	 NNS	I-NP
.  	.  	 .	O
Restricted  	Restricted  	 JJ	B-NP
drug  	drug  	 NN	I-NP
distribution  	distribution  	 NN	I-NP
systems  	systems  	 NNS	I-NP
established  	established  	 VBN	O
by  	by  	 IN	O
pharmaceutical  	pharmaceutical  	 JJ	B-NP
manufacturers 	manufacturers 	 NNS	I-NP
,  	,  	 ,	O
specialty  	specialty  	 NN	B-NP
pharmacies 	pharmacies 	 NNS	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
other  	other  	 JJ	O
specialty  	specialty  	 NN	B-NP
suppliers  	suppliers  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
component  	component  	 NN	O
of  	of  	 IN	O
REMS 	REMS 	 NNP	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
are  	are  	 VBP	O
required  	required  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Food  	Food  	 NNP	O
and  	and  	 CC	O
Drug  	Drug  	 NNP	B-NP
Administration  	Administration  	 NNP	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
management  	management  	 NN	O
of  	of  	 IN	O
known  	known  	 VBN	O
or  	or  	 CC	O
potential  	potential  	 JJ	B-NP
serious  	serious  	 JJ	I-NP
risks  	risks  	 NNS	I-NP
from  	from  	 IN	O
certain  	certain  	 JJ	O
drugs 	drugs 	 NNS	O
.  	.  	 .	O
Concerns  	Concerns  	 NNS	O
of  	of  	 IN	O
health-system  	health-system  	 JJ	B-NP
pharmacists  	pharmacists  	 NNS	I-NP
using  	using  	 VBG	O
specialty  	specialty  	 NN	B-NP
suppliers  	suppliers  	 NNS	I-NP
include  	include  	 VBP	O
access  	access  	 NN	O
to  	to  	 TO	O
pharmaceuticals 	pharmaceuticals 	 NNS	O
,  	,  	 ,	O
operational  	operational  	 JJ	B-NP
challenges 	challenges 	 NNS	I-NP
,  	,  	 ,	O
product  	product  	 NN	B-NP
integrity 	integrity 	 NN	I-NP
,  	,  	 ,	O
financial  	financial  	 JJ	B-NP
implications 	implications 	 NNS	I-NP
,  	,  	 ,	O
continuity  	continuity  	 NN	O
of  	of  	 IN	O
care 	care 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
patient  	patient  	 JJ	O
safety 	safety 	 NN	O
.  	.  	 .	O
An  	An  	 DT	O
ambulatory  	ambulatory  	 JJ	B-NP
care  	care  	 NN	I-NP
patient  	patient  	 NN	I-NP
taking  	taking  	 VBG	O
a  	a  	 DT	O
specialty  	specialty  	 NN	B-NP
drug  	drug  	 NN	I-NP
product  	product  	 NN	I-NP
from  	from  	 IN	O
home  	home  	 NN	O
to  	to  	 TO	O
a  	a  	 DT	O
hospital  	hospital  	 NN	O
outpatient  	outpatient  	 NN	O
clinic  	clinic  	 NN	O
or  	or  	 CC	O
inpatient  	inpatient  	 JJ	B-NP
setting  	setting  	 NN	I-NP
for  	for  	 IN	I-NP
administration 	administration 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
practice  	practice  	 NN	O
known  	known  	 VBN	O
as  	as  	 IN	O
brown  	brown  	 JJ	O
bagging 	bagging 	 NN	O
,  	,  	 ,	O
raises  	raises  	 VBZ	O
concerns  	concerns  	 NNS	O
about  	about  	 IN	O
product  	product  	 NN	B-NP
integrity  	integrity  	 NN	I-NP
and  	and  	 CC	O
institutional  	institutional  	 JJ	B-NP
liability 	liability 	 NN	I-NP
.  	.  	 .	O
An  	An  	 DT	O
institution 	institution 	 NN	O
's  	's  	 POS	O
finances 	finances 	 NNS	O
,  	,  	 ,	O
tolerance  	tolerance  	 NN	O
for  	for  	 IN	O
liability 	liability 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
skillfully  	skillfully  	 VB	O
manage  	manage  	 VB	O
the  	the  	 DT	O
processes  	processes  	 VBZ	O
involved  	involved  	 VBN	O
often  	often  	 RB	O
determine  	determine  	 VB	O
its  	its  	 PRP$	O
choice  	choice  	 NN	O
between  	between  	 IN	O
an  	an  	 DT	O
approach  	approach  	 NN	O
that  	that  	 WDT	O
prohibits  	prohibits  	 VBZ	O
brown  	brown  	 JJ	O
bagging  	bagging  	 NN	O
but  	but  	 CC	O
is  	is  	 VBZ	O
costly  	costly  	 JJ	O
and  	and  	 CC	O
one  	one  	 CD	O
that  	that  	 WDT	O
permits  	permits  	 VBZ	O
the  	the  	 DT	O
practice  	practice  	 NN	O
under  	under  	 IN	O
certain  	certain  	 JJ	O
conditions  	conditions  	 NNS	O
and  	and  	 CC	O
is  	is  	 VBZ	O
less  	less  	 RBR	O
costly 	costly 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
recent  	recent  	 JJ	O
shift  	shift  	 NN	O
from  	from  	 IN	O
a  	a  	 DT	O
traditional  	traditional  	 JJ	O
supply  	supply  	 NN	B-NP
chain  	chain  	 NN	I-NP
model  	model  	 NN	I-NP
to  	to  	 TO	O
a  	a  	 DT	O
specialty  	specialty  	 NN	B-NP
pharmacy  	pharmacy  	 NN	I-NP
supply  	supply  	 NN	I-NP
chain  	chain  	 NN	I-NP
model  	model  	 NN	I-NP
for  	for  	 IN	I-NP
high-cost  	high-cost  	 JJ	I-NP
pharmaceuticals  	pharmaceuticals  	 NNS	I-NP
has  	has  	 VBZ	O
the  	the  	 DT	O
potential  	potential  	 JJ	O
to  	to  	 TO	O
increase  	increase  	 VB	O
pharmaceutical  	pharmaceutical  	 JJ	B-NP
costs  	costs  	 NNS	I-NP
for  	for  	 IN	I-NP
health  	health  	 NN	I-NP
systems 	systems 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
dialogue  	dialogue  	 NN	O
is  	is  	 VBZ	O
needed  	needed  	 VBN	O
between  	between  	 IN	O
health-system  	health-system  	 JJ	B-NP
pharmacists  	pharmacists  	 NNS	I-NP
and  	and  	 CC	O
group  	group  	 NN	B-NP
purchasing  	purchasing  	 NN	I-NP
organizations  	organizations  	 NNS	I-NP
to  	to  	 TO	O
address  	address  	 VB	O
the  	the  	 DT	O
latter 	latter 	 NN	O
's  	's  	 POS	O
role  	role  	 NN	O
in  	in  	 IN	O
mitigating  	mitigating  	 VBG	O
the  	the  	 DT	O
financial  	financial  	 JJ	B-NP
implications  	implications  	 NNS	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
change  	change  	 NN	O
and  	and  	 CC	O
to  	to  	 TO	O
help  	help  	 VB	O
clarify  	clarify  	 VB	O
the  	the  	 DT	O
safety  	safety  	 NN	O
issues 	issues 	 NNS	O
.  	.  	 .	O
Some  	Some  	 DT	O
health  	health  	 NN	B-NP
plans  	plans  	 NNS	I-NP
have  	have  	 VBP	O
shifted  	shifted  	 VBN	B-NP
part  	part  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
cost  	cost  	 NN	O
of  	of  	 IN	O
expensive  	expensive  	 JJ	B-NP
drugs  	drugs  	 NNS	I-NP
to  	to  	 TO	O
patients  	patients  	 NNS	O
by  	by  	 IN	O
establishing  	establishing  	 VBG	O
a  	a  	 DT	O
fourth  	fourth  	 JJ	O
tier  	tier  	 NN	O
of  	of  	 IN	O
drugs  	drugs  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
large  	large  	 JJ	O
copayment  	copayment  	 NNS	B-NP
based  	based  	 VBN	O
on  	on  	 IN	O
a  	a  	 DT	O
substantial  	substantial  	 JJ	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cost  	cost  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
drug 	drug 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
number  	number  	 NN	O
and  	and  	 CC	O
cost  	cost  	 NN	O
of  	of  	 IN	O
specialty  	specialty  	 NN	B-NP
drugs  	drugs  	 NNS	I-NP
are  	are  	 VBP	O
expected  	expected  	 VBN	O
to  	to  	 TO	O
increase  	increase  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
future 	future 	 NN	O
.  	.  	 .	O
New  	New  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
and  	and  	 CC	O
reimbursement  	reimbursement  	 JJ	B-NP
models  	models  	 NNS	I-NP
are  	are  	 VBP	O
emerging  	emerging  	 VBG	O
to  	to  	 TO	O
manage  	manage  	 VB	O
the  	the  	 DT	O
high  	high  	 JJ	O
cost  	cost  	 NN	O
of  	of  	 IN	O
new  	new  	 JJ	O
pharmaceuticals 	pharmaceuticals 	 NNS	O
.  	.  	 .	O
Health-system  	Health-system  	 JJ	B-NP
pharmacists  	pharmacists  	 NNS	I-NP
can  	can  	 MD	O
improve  	improve  	 VB	O
drug  	drug  	 NN	B-NP
safety  	safety  	 NN	I-NP
and  	and  	 CC	O
manage  	manage  	 VB	O
costs  	costs  	 NNS	O
by  	by  	 IN	O
collaborating  	collaborating  	 VBG	O
with  	with  	 IN	O
group  	group  	 NN	B-NP
purchasing  	purchasing  	 NN	I-NP
organizations 	organizations 	 NNS	I-NP
,  	,  	 ,	O
establishing  	establishing  	 VBG	B-NP
policies  	policies  	 NNS	I-NP
for  	for  	 IN	O
brown  	brown  	 JJ	O
bagging 	bagging 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
making  	making  	 VBG	B-NP
efforts  	efforts  	 NNS	I-NP
to  	to  	 TO	O
reconcile  	reconcile  	 VB	O
drug  	drug  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
provided  	provided  	 VBN	O
in  	in  	 IN	O
different  	different  	 JJ	O
settings  	settings  	 NNS	O
through  	through  	 IN	O
traditional  	traditional  	 JJ	O
drug  	drug  	 NN	B-NP
channels  	channels  	 NNS	I-NP
and  	and  	 CC	O
specialty  	specialty  	 NN	B-NP
pharmacies  	pharmacies  	 NNS	I-NP
or  	or  	 CC	O
other  	other  	 JJ	O
restricted  	restricted  	 JJ	O
drug  	drug  	 NN	B-NP
distribution  	distribution  	 NN	I-NP
systems 	systems 	 NNS	I-NP
.  	.  	 .	O
